AAAAAA

   
Results: 1-8 |
Results: 8
Meta-analysis of binary data: which within study variance estimate to use?
Authors: Chang, BH Waternaux, C Lipsitz, S
Citation: Bh. Chang et al., Meta-analysis of binary data: which within study variance estimate to use?, STAT MED, 20(13), 2001, pp. 1947-1956
Depletion of protein kinase C epsilon in normal and scleroderma lung fibroblasts has opposite effects on tenascin expression
Authors: Tourkina, E Hoffman, S Fenton, JW Lipsitz, S Silver, RM Ludwicka-Bradley, A
Citation: E. Tourkina et al., Depletion of protein kinase C epsilon in normal and scleroderma lung fibroblasts has opposite effects on tenascin expression, ARTH RHEUM, 44(6), 2001, pp. 1370-1381
Analysis of dichotomous outcome data for community intervention studies
Authors: Bellamy, SL Gibberd, R Hancock, L Howley, P Kennedy, B Klar, N Lipsitz, S Ryan, L
Citation: Sl. Bellamy et al., Analysis of dichotomous outcome data for community intervention studies, STAT ME M R, 9(2), 2000, pp. 135-159
Treatment of squamous cell esophageal cancer with topotecan - An Eastern Cooperative Oncology Group study (E2293)
Authors: Asbury, RF Lipsitz, S Graham, D Falkson, CI Baez, L Benson, AB
Citation: Rf. Asbury et al., Treatment of squamous cell esophageal cancer with topotecan - An Eastern Cooperative Oncology Group study (E2293), AM J CL ONC, 23(1), 2000, pp. 45-46
A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancer
Authors: Witte, RS Lipsitz, S Goodman, TL Asbury, RF Wilding, G Strnad, CM Smith, TJ Haller, DG
Citation: Rs. Witte et al., A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancer, INV NEW DR, 17(2), 1999, pp. 173-177
Phase II trial of trimetrexate for patients with advanced gastric carcinoma - An Eastern Cooperative Oncology Group Study (E1287)
Authors: Ramanathan, RK Lipsitz, S Asbury, RF Qazi, R Greenberg, BR Haller, DG
Citation: Rk. Ramanathan et al., Phase II trial of trimetrexate for patients with advanced gastric carcinoma - An Eastern Cooperative Oncology Group Study (E1287), CANCER, 86(4), 1999, pp. 572-576
A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma - AnEastern Cooperative Oncology Group Study (E5292)
Authors: Hudes, GR Lipsitz, S Grem, J Morrisey, M Weiner, L Kugler, JW Benson, A
Citation: Gr. Hudes et al., A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma - AnEastern Cooperative Oncology Group Study (E5292), CANCER, 85(2), 1999, pp. 290-294
Using a hypothetical case to measure differences in treatment aggressiveness among physicians in Canada, Germany and the United States
Authors: Koeck, CM Hemenway, D Donelan, K Lipsitz, S
Citation: Cm. Koeck et al., Using a hypothetical case to measure differences in treatment aggressiveness among physicians in Canada, Germany and the United States, WIEN KLIN W, 110(22), 1998, pp. 783-788
Risultati: 1-8 |